

Cardiosalin 75, 150 and 160 mg film-coated tablets
Group: Antithrombotic agents: platelet aggregation inhibitors excl. heparin.
Indications: Cardiosalin contains acetylsalicylic acid, which in low doses belongs to a group of medicines called antithrombotic agents.
Platelets are a type of blood cell that causes blood to clot and are involved in the formation of blood clots. When a blood clot forms in an artery, blood flow is disrupted and the supply of oxygen to the tissues is interrupted, which can cause the development of paroxysmal chest pain (angina pectoris), heart attack, stroke, pulmonary embolism and others.
Applied in low doses, acetylsalicylic acid reduces the ability of platelets to stick together and adhere to the walls of blood vessels, resulting in a reduced risk of blood clots (thrombi).
Cardiosalin is used to reduce the risk of blood clots and thus prevent the development of:
– heart attacks;
– strokes;
– cardiovascular problems in patients suffering from stable and unstable angina (a type of chest pain).
Cardiosalin is also used to prevent the formation of blood clots (thrombi) after certain types of heart surgery, in order to dilate or unblock blood vessels.
Prescription: OTC medicinal product
Each film-coated tablet contains 75, 150 or 160 mg acetylsalicylic acid.
No information available.
Read the leaflet before use.
Download leaflet
